United States · FDA National Drug Code directory
Diclofenac Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-201_504b1904-033c-4fd8-92c9-41e31154f808
- Product NDC
- 16571-201
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Diclofenac Sodium
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080819
- Source listing expiry
- 20261231
Source-listed ingredients
- DICLOFENAC SODIUM — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (16571-201-06) · 16571-201-06
- 100 TABLET, DELAYED RELEASE in 1 BOTTLE (16571-201-10) · 16571-201-10
- 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (16571-201-11) · 16571-201-11
- 500 TABLET, DELAYED RELEASE in 1 BOTTLE (16571-201-50) · 16571-201-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →